Bridging the divide: The need for translational informatics

Pharmacogenomics

Volumn 7, Issue 1, 2006, Pages 117-122

  Gaughan, Andy ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

AstraZeneca; Biomarker; Data management; Informatics; Knowledge management; Tanslational science

Indexed keywords

BIOLOGICAL MARKER; DRUG;

ARTICLE; DATA ANALYSIS; DRUG EFFICACY; DRUG INDUSTRY; DRUG QUALITY; DRUG RESEARCH; DRUG SAFETY; MEDICAL INFORMATICS; PHARMACOGENETICS; RISK MANAGEMENT; RNA TRANSLATION; HUMAN; PHARMACOLOGY; REVIEW;

HUMANS; MEDICAL INFORMATICS; PHARMACOLOGY;

EID: 33644875860     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/14622416.7.1.117     Document Type: Article

References (4)

1. Lumpkin M: Re-engineering discovery and development. Presentation at the InfoTechPharma® Conference, London, UK, March 15-16, 2005.
2. Ruffolo RR: Strategy for re-engineering discovery and development to address R&D productivity. Presentation at the InfoTechPharma Conferene, London, UK, March 15-16., 2005.
3. Pardridge WM: Translational science: what is it and why is it important? Drug Discov. Today 8, 813-815 (2003).
4. Hu H, Brzeski H, Hutchins J: Biomedical informatics: development of a comprehensive data warehouse for clinical and genomic breast cancer research. Pharmacogenomics 5, 933-941 (2004).